These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 9337443)

  • 1. Topiramate: a new antiepileptic drug.
    Privitera MD
    Ann Pharmacother; 1997 Oct; 31(10):1164-73. PubMed ID: 9337443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topiramate. Clinical profile in epilepsy.
    Sachdeo RC
    Clin Pharmacokinet; 1998 May; 34(5):335-46. PubMed ID: 9592618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and safety of adjunctive topiramate in infants (1-24 months) with refractory partial-onset seizures: a randomized, multicenter, open-label phase 1 study.
    Manitpisitkul P; Shalayda K; Todd M; Wang SS; Ness S; Ford L
    Epilepsia; 2013 Jan; 54(1):156-64. PubMed ID: 23157581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pharmacological and clinical review on topiramate, a new antiepileptic drug.
    Perucca E
    Pharmacol Res; 1997 Apr; 35(4):241-56. PubMed ID: 9264038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topiramate: a review of its use in the treatment of epilepsy.
    Lyseng-Williamson KA; Yang LP
    Drugs; 2007; 67(15):2231-56. PubMed ID: 17927286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Topiramate YD Study Group.
    Faught E; Wilder BJ; Ramsay RE; Reife RA; Kramer LD; Pledger GW; Karim RM
    Neurology; 1996 Jun; 46(6):1684-90. PubMed ID: 8649570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topiramate.
    Glauser TA
    Semin Pediatr Neurol; 1997 Mar; 4(1):34-42. PubMed ID: 9097365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topiramate. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy.
    Langtry HD; Gillis JC; Davis R
    Drugs; 1997 Nov; 54(5):752-73. PubMed ID: 9360061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary observations on topiramate in pediatric epilepsies.
    Glauser TA
    Epilepsia; 1997; 38 Suppl 1():S37-41. PubMed ID: 9092958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of topiramate in childhood generalized seizure disorders.
    Wheless JW
    J Child Neurol; 2000; 15 Suppl 1():S7-13. PubMed ID: 11218056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topiramate.
    Glauser TA
    Epilepsia; 1999; 40 Suppl 5():S71-80. PubMed ID: 10530697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topiramate: a new antiepileptic drug.
    Markind JE
    Am J Health Syst Pharm; 1998 Mar; 55(6):554-62. PubMed ID: 9544331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topiramate: a review of its use in childhood epilepsy.
    Ormrod D; McClellan K
    Paediatr Drugs; 2001; 3(4):293-319. PubMed ID: 11354701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topiramate therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs.
    Contin M; Riva R; Albani F; Avoni P; Baruzzi A
    Ther Drug Monit; 2002 Jun; 24(3):332-7. PubMed ID: 12021622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.
    French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ; ;
    Epilepsia; 2004 May; 45(5):410-23. PubMed ID: 15101822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topiramate titration to response: analysis of individualized therapy study (TRAITS).
    Dodson WE; Kamin M; Kraut L; Olson WH; Wu SC
    Ann Pharmacother; 2003 May; 37(5):615-20. PubMed ID: 12708932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of topiramate.
    Bruni J
    Can J Neurol Sci; 1998 Aug; 25(3):S6-7. PubMed ID: 9706733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topiramate as an adjunctive treatment for refractory partial epilepsy in the elderly.
    Zhang L; Huang J; Zhuang JH; Huang LQ; Zhao ZX
    J Int Med Res; 2011; 39(2):408-15. PubMed ID: 21672344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose topiramate in adults with treatment-resistant partial-onset seizures.
    Guberman A; Neto W; Gassmann-Mayer C;
    Acta Neurol Scand; 2002 Oct; 106(4):183-9. PubMed ID: 12225311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term safety and sustained efficacy of USL255 (topiramate extended-release capsules) in patients with refractory partial-onset seizures.
    Chung SS; Hogan RE; Blatt I; Lawson P B; Nguyen H; Clark AM; Anders B; Halvorsen MB;
    Epilepsy Behav; 2016 Jun; 59():13-20. PubMed ID: 27084978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.